脑膜瘤临床试验招募信息（全球在招）

这里汇总了全球正在招募患者的 脑膜瘤（国际通用名 meningioma）新药临床试验，包含试验分期、招募状态、开展国家和研究团队联系方式，全部以中文呈现。数据实时来自全球最大的临床试验注册库 ClinicalTrials.gov。

正在招募的脑膜瘤新药试验

• NK Cell Therapy for Malignant Solid Brain Tumors

  不适用招募中中国NCT07552233

• Predictive Factors for Survival in Aggressive Meningiomas

  不适用招募中意大利NCT05793034

• Longitudinal Prospective Study of Neurocognition & Neuroimaging in Primary BT Patients

  不适用招募中美国NCT05576103

• A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma

  II 期招募中美国NCT07533942

• Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectable Brain Tumors

  I 期招募中美国NCT06650163

• Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors

  I 期 / II 期招募中美国NCT05636618

• Analysis of Cerebrospinal Fluid Leakage After Surgery for Intracranial Tumors

  不适用招募中PolandNCT07411690

• Long-term Cognitive and Functional Impact of Proton-therapy or Modern Fractionated Radiotherapy in Cavernous Sinus Meningioma: An Open-label Randomized 1:1 Phase III Study

  不适用招募中法国NCT05895344

• Adjuvant Hypofractionated Stereotactic Radiosurgery for Intermediate-risk Meningioma

  不适用招募中美国NCT06557512

• Embolization for Meningioma

  不适用招募中NorwayNCT05416567

• Feasibility of Intraoperative Tracing of Meningioma Using [Cu64]DOTATATE

  IV 期招募中美国NCT06377371

• Post-Operative Dosing of Dexamethasone in Patients With Brain Tumors After a Craniotomy, PODS Trial

  II 期招募中美国NCT06132685